HLA class I alleles and cervical neoplasia [2]

Journal of Infectious Diseases

Volumn 187, Issue 10, 2003, Pages 1675-1676

  Visser, Jeroen T J ^a,b   Hoogeboom, Baukje Nynke ^a   Reesink Peters, Nathalie ^a   Klip, Harry ^a   Hepkema, Bouke ^a   Van Velde, Hans ^a   Van Der Zee, Ate G J ^a   Daemen, Toos ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1;

GENE FREQUENCY; HLA TYPING; HUMAN; LETTER; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; UTERINE CERVIX TUMOR; WART VIRUS;

ALLELES; CONTINENTAL POPULATION GROUPS; COSTA RICA; FEMALE; GENES, MHC CLASS I; GENETIC PREDISPOSITION TO DISEASE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UNITED STATES; UTERINE CERVICAL NEOPLASMS;

EID: 0037907254     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/374938     Document Type: Letter

References (7)

1. Wang SS, Hildesheim A, Gao X, et al. Comprehensive analysis of human leukocyte antigen class I alleles and cervical neoplasia in 3 epidemiologic studies. J Infect Dis 2002; 186:598-605.
2. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-9.
3. Franco EL, Villa LL, Sobrinho JP, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. J Infect Dis 1999; 180:1415-23.
4. Nakagawa M, Sites DP, Patel S, et al. Persistence of human papillomavirus type 16 infection is associated with lack of cytotoxic T lymphocyte response to the E6 antigens. J Infect Dis 2000; 182:595-8.
5. Kadish AS, Timmins P, Wang Y, et al. Regression of cervical intraepithelial neoplasia and loss of human papillomavirus (HPV) infection is associated with cell-mediated immune responses to an HPV type 16 E7 peptide. Cancer Epidemiol Biomarkers Prev 2002; 11:483-8.
6. Ressing ME, Sette A, Brandt RM, et al. Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 indentified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides. J Immunol 1995; 154:5934-43.
7. Rudolf MP, Man S, Melief CJ, Sette A, Kast WM. Human T-cell responses to HLA-A-restricted high binding affinity peptides of human papillomavirus type 18 proteins E6 and E7. Clin Cancer Res 2001; 7(Suppl):788s-95s.